These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15452964)

  • 1. Abstracts of the 2004 APS Translational Research Conference: Immunological and Pathophysiological Mechanisms in Inflammatory Bowel Disease. September 8-11, 2004, Colorado, USA.
    Physiologist; 2004 Aug; 47(4):221-40. PubMed ID: 15452964
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease.
    Shanahan F
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G417-21. PubMed ID: 15701620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International meeting on inflammatory bowel disease. Trigger factors and trends in therapy. Capri, Italy, September 19-21, 1996. Abstracts.
    Ital J Gastroenterol; 1996 Sep; 28 Suppl 1():1-40. PubMed ID: 8954199
    [No Abstract]   [Full Text] [Related]  

  • 4. Signposts to therapy: recent advances in inflammatory bowel disease research.
    Hamilton J
    CMAJ; 1996 May; 154(10):1513-6. PubMed ID: 8625002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the epithelial barrier in inflammatory bowel disease.
    Nieuwenhuis EE; Blumberg RS
    Adv Exp Med Biol; 2006; 579():108-16. PubMed ID: 16620014
    [No Abstract]   [Full Text] [Related]  

  • 6. Abstracts from the 2006 CCFA National Research and Clinical Conference 5th Annual Advances in the Inflammatory Bowel Diseases, December 1-3, 2006, Miami, Florida, USA.
    Inflamm Bowel Dis; 2007 May; 13(5 Suppl):643-74. PubMed ID: 17536232
    [No Abstract]   [Full Text] [Related]  

  • 7. Abstracts from the 2007 CCFA National Research and Clinical Conference 6th Annual Advances in the Inflammatory Bowel Diseases, December 6-9, 2007, Aventura, Florida, USA.
    Inflamm Bowel Dis; 2008 Jan; 14(1 Suppl):S1-39. PubMed ID: 18232082
    [No Abstract]   [Full Text] [Related]  

  • 8. [The cytokines in inflammatory bowel disease].
    Polińska B; Matowicka-Karna J; Kemona H
    Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response?
    Stenson WF
    Gastroenterology; 1995 Jan; 108(1):284-6. PubMed ID: 7806051
    [No Abstract]   [Full Text] [Related]  

  • 10. Of mice and men: what to learn about human inflammatory bowel disease from genetic analysis of murine inflammation.
    Schreiber S
    Gastroenterology; 2005 Nov; 129(5):1782-4. PubMed ID: 16285973
    [No Abstract]   [Full Text] [Related]  

  • 11. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.
    Rijnierse A; Nijkamp FP; Kraneveld AD
    Pharmacol Ther; 2007 Nov; 116(2):207-35. PubMed ID: 17719089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The puzzle of somatostatin: action, receptors, analogues and therapy.
    Panteris V; Karamanolis DG
    Hepatogastroenterology; 2005; 52(66):1771-81. PubMed ID: 16334776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory bowel diseases--pathogenesis and clinical symptoms].
    Wojtuń S; Gil J; Wichan P; Chojnacki J
    Pol Merkur Lekarski; 2004; 17 Suppl 1():9-13. PubMed ID: 15603338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.
    Kraneveld AD; Rijnierse A; Nijkamp FP; Garssen J
    Eur J Pharmacol; 2008 May; 585(2-3):361-74. PubMed ID: 18417115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
    Danese S
    Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of matrix metalloproteinases in inflammatory bowel disease.
    Naito Y; Yoshikawa T
    Mol Aspects Med; 2005; 26(4-5):379-90. PubMed ID: 16112187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of inflammatory bowel disease: evolving concepts.
    Mayer L; Yio XY; Lin A; Panja A
    Mt Sinai J Med; 1996; 63(3-4):202-9. PubMed ID: 8692166
    [No Abstract]   [Full Text] [Related]  

  • 18. Current perspectives in inflammatory bowel disease: stress response and autophagy, host-microbe mutualism, immune duality and plasticity, and early versus late disease.
    Fiocchi C
    Curr Opin Gastroenterol; 2010 Jul; 26(4):299-301. PubMed ID: 20571383
    [No Abstract]   [Full Text] [Related]  

  • 19. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative biology of exercise. APS conference. Colorado Springs, Colorado, September 23-26, 1992. Abstracts.
    Physiologist; 1992 Aug; 35(4):167-245. PubMed ID: 1409897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.